Anion gap, anion gap corrected for albumin, base deficit and unmeasured anions in critically ill patients: implications on the assessment of metabolic acidosis and the diagnosis of hyperlactatemia by Davison Danielle et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Emergency Medicine
Open Access Research article
Anion gap, anion gap corrected for albumin, base deficit and 
unmeasured anions in critically ill patients: implications on the 
assessment of metabolic acidosis and the diagnosis of 
hyperlactatemia
Lakhmir S Chawla*1,2, Shirley Shih1, Danielle Davison1, Christopher Junker1 
and Michael G Seneff1
Address: 1Department of Critical Care Medicine and Anesthesiology, George Washington University Medical Center, Washington DC, USA and 
2Division of Renal Diseases and Hypertension, Department of Medicine, George Washington University Medical Center, Washington DC, USA
Email: Lakhmir S Chawla* - lchawla@mfa.gwu.edu; Shirley Shih - rigriam@yahoo.com; Danielle Davison - ddavison@mfa.gwu.edu; 
Christopher Junker - cjunker@gmail.com; Michael G Seneff - mseneff@mfa.gwu.edu
* Corresponding author    
Abstract
Background: Base deficit (BD), anion gap (AG), and albumin corrected anion gap (ACAG) are
used by clinicians to assess the presence or absence of hyperlactatemia (HL). We set out to
determine if these tools can diagnose the presence of HL using cotemporaneous samples.
Methods: We conducted a chart review of ICU patients who had cotemporaneous arterial blood
gas, serum chemistry, serum albumin (Alb) and lactate(Lac) levels measured from the same sample.
We assessed the capacity of AG, BD, and ACAG to diagnose HL and severe hyperlactatemia (SHL).
HL was defined as Lac > 2.5 mmol/L. SHL was defined as a Lac of > 4.0 mmol/L.
Results: From 143 patients we identified 497 series of lab values that met our study criteria. Mean
age was 62.2 ± 15.7 years. Mean Lac was 2.11 ± 2.6 mmol/L, mean AG was 9.0 ± 5.1, mean ACAG
was 14.1 ± 3.8, mean BD was 1.50 ± 5.4. The area under the curve for the ROC for BD, AG, and
ACAG to diagnose HL were 0.79, 0.70, and 0.72, respectively.
Conclusion:  AG and BD failed to reliably detect the presence of clinically significant
hyperlactatemia. Under idealized conditions, ACAG has the capacity to rule out the presence of
hyperlactatemia. Lac levels should be obtained routinely in all patients admitted to the ICU in whom
the possibility of shock/hypoperfusion is being considered. If an AG assessment is required in the
ICU, it must be corrected for albumin for there to be sufficient diagnostic utility.
Background
The use of anion gap assessment to interpret and diagnose
the etiology of metabolic acidosis was originally described
by Emmet and Narins in 1977.[1] Lactic acid, a "gap" acid,
is one cause of elevated anion gap metabolic acidosis, and
an elevated serum lactate level has emerged as an impor-
tant tool to screen for patients in shock. Elevated serum
lactate can be caused by inadequate perfusion, but may
also be a product of inflammation, cytopathic hypoxia,
and increased rates of glycolysis. [2-4] In critically ill
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patients, an elevated lactate level is indicative of increased
severity of illness and subsequent serum lactate clearance
predicts an improved outcome.[5,6] Rivers et al, utilized
hypotension and elevated serum lactate levels to identify
patients in shock and demonstrated that emergency
department patients with presumed sepsis and a serum
lactate level of ≥ 4.0 mmol/L and/or frank hypotension
are at a significant risk of death (38–59% mortality).[7]
Despite this study and multiple other investigations that
document the value of measuring serum lactate concen-
trations, the measurement of serum lactate is still not rou-
tine. In fact, in some institutions, serum lactate remains a
"send out" test (unpublished data, Table 1). We believe
that one reason the measurement of serum lactate is not
part of a standard admission battery of laboratory tests is
that clinicians assume other commonly measured and cal-
culated lab values, such as anion gap (AG) and base deficit
(BD), accurately identify the presence or absence of hyper-
lactatemia. Despite previous studies showing that neither
base deficit nor anion gap are effective at discriminating
between the presence or absence of hyperlactatemia, [8-
12] there persists the commonly held belief that a normal
anion gap or the absence of base deficit rules out the pres-
ence of hyperlactatemia.
One possible reason for this discrepancy is that hypoalbu-
minemia, a common finding in critically ill patients, can
cause a decrease in the "normal" measured anion gap and
thereby mask the presence of an elevated anion gap.[13]
Therefore, some investigators have suggested that anion
gap corrected for albumin (ACAG) is a more appropriate
screening tool for the diagnosis of metabolic acidosis in
the ICU.[14] We recently published a study wherein we
describe the limited utility of anion gap, anion gap cor-
rected for albumin, and base deficit to diagnose the pres-
ence of hyperlactatemia in critically ill patients.[15] In
that study, we based our retrospective analysis on labora-
tory results that were obtained on admission to the inten-
sive care unit (ICU). The major limitation of that study
was the fact that we could not be certain if the measured
values were drawn contemporaneously. We set out to ver-
ify the results of this and other previous studies, using
cotemporaneous arterial samples in a larger and more
diverse population of critically ill patients.
Methods
This study was conducted from September 2005 to August
2006 in the George Washington University Hospital ICU.
This ICU is a closed, 48 bed combined medical-surgical
unit that admits all critically ill adults, except those with
major thermal injuries. A waiver of informed consent and
HIPPA was obtained from the Institutional Review Board
(IRB) because the study involved prospective chart review
only. We obtained a HIPAA waiver from the George Wash-
ington University Committee on Human Research and
the privacy officer of the hospital.
Patients
We reviewed the records of all medical-surgical ICU
admissions over a 12-month time span. Demographic,
admission diagnoses, clinical, and biochemical data were
collected from the chart for all patients entered into the
cohort. We enrolled patients who had arterial lines in
place as part of their ICU care and who also had cotempo-
raneous arterial blood gas, serum chemistry, serum albu-
min and a serum lactate level measured from the same
sample available for review. Patients with a serum creati-
nine > 6.0 mg/dl, a diagnosis of ketoacidosis, or with a
recent history or syndrome consistent with a toxic inges-
tion (e.g. ethanol, ethylene glycol, methanol, salicylates,
toluene, citrate, iron, or isoniazid), and those treated with
renal replacement therapy were excluded.
Definitions and Analysis
For each patient, standard base deficit, anion gap, and
anion gap corrected for serum albumin were calculated.
Standard base deficit (BD) was determined using the
modified Van Slyke equation.[16] Anion gap (AG) was
Table 1: Availability of serum lactate in Washington DC metro area hospitals
Hospital # of ICU Beds Lac run on-site Lac run automatically with 
ABG?
Serum lactate must be ordered 
separately?
George Washington University 
Hospital
45 Yes Yes Separate or comes with ABG
Georgetown University Hospital 25 Yes Yes Separate or comes with ABG
Washington Hospital Center 60 Yes No Yes
Holy Cross Hospital 42 Yes No Yes
Sibley Hospital 14 Yes No Yes
Suburban Hospital 44 Yes No Yes
Providence Hospital 17 Yes No Yes
Specialty Hospital 22 No No Yes
Fairfax Hospital 60 Yes No Yes
Alexandria Hospital 30 Yes Yes Separate or comes with ABG
Washington Adventist Hospital 36 Yes No YesBMC Emergency Medicine 2008, 8:18 http://www.biomedcentral.com/1471-227X/8/18
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calculated using the formula [Na] - ([Cl] + [HCO3]).
Albumin corrected anion gap (ACAG) was calculated
using the Figge equation: ({4.4 - [observed serum albu-
min (g/dL)] × 2.5} + AG).[13] Hyperlactatemia was
defined as a serum lactate concentration > 2.5 mmol/L
(1.0 mmol/L above our lab's upper limit of normal), and
severe hyperlacatatemia was defined as a serum lactate >
4.0 mmol/L. Anion gap corrected for albumin and serum
lactate (ALCAG) was calculated with the following equa-
tion: ({4.4 - [observed serum albumin (g/dL)] × 0.25} +
AG) - [serum lactate (mmol/L)]. Patients with a serum cre-
atinine less than or equal to 2.0 mg/dl were also analyzed
separately.
Statistics
Proportions of patients with certain characteristics were
compared using the chi-square test. We assessed the distri-
bution of variables. AG, BD, and ACAG were compared
using Pearson correlations. Receiver operating characteris-
tic (ROC) curves were determined for AG, BD, and ACAG
to detect the presence of hyperlactatemia. Unless other-
wise specified, all means are reported as ± S.D. All statis-
tics were performed with SPSS 11.0 (SPSS, Chicago, IL.).
The cohort was analyzed with all of the samples from each
of the patients, and the cohort was analyzed with only one
sample from each patient in order to ascertain if the sam-
ples per subject skewed the results.
Results
We reviewed 1300 consecutive admissions to the ICU
from September 2005 to August 2006. One hundred and
forty three patients met our inclusion/exclusion criteria.
From those patients we identified 497 series of lab values
that had an ABG, serum chemistry, and a serum lactate
measured from the same arterial sample available for
review. Of the 497 subjects, 311 also had a cotemporane-
ous serum albumin available. The mean age was 62.2 ±
15.7 years and 41.3% of the patients were female. Within
the cohort, 51.0% of the patients were African American,
42.7% of the patients European American, 4.9% of the
patients Hispanic, and 0.7% of the patients Asian Ameri-
can. Among the 497 sets of laboratory results, hyperlac-
tatemia was present in 16.3% of the patients based on the
initial lab values. The serum lactate range was 0.5 to 17.0
mmol/L and the mean serum lactate was 2.11 ± 2.6
mmol/L. The mean serum albumin was 2.5 ± 0.80 g/dl,
mean anion gap was 9.0 ± 5.1 meq/L, mean ACAG was
14.1 ± 3.8 meq/L, mean BD was 1.50 ± 5.35, and mean
ALCAG was 12.6 ± 3.60 meq/L, Table 2. Sensitivity, specif-
icity, and ROC area under the curve for AG, BD, and
ACAG for varying serum lactate thresholds are presented
in Tables 3 and 4. Similar analyses where conducted in the
patients with a serum creatinine of ≤ 2.0 mg/dl (Table 6).
These results did not significantly differ from those of the
entire cohort. In addition, the analysis of using each
patient to contribute only one sample to the cohort were
not significantly different from the results presented (data
not shown).
Discussion
In this study, we showed that base deficit (BD) and anion
gap (AG) are poor tests to diagnose the presence of hyper-
lactatemia (serum lactate > 2.5 mmol/L). AG has a clinical
threshold of 10–12 meq/L. At these values, AG performs
quite poorly in predicting the presence of hyperlactatemia
Table 2: Demographics and patient characteristics
Age, years 62.2 (15.7)
Gender (% male) 59.7%
Ethnicity
European American 42.7%
African American 51.0%
Hispanic 4.9%
Asian American 0.7%
Surgical Patients 56.2%
Serum Albumin, g/dL 2.5 (0.86)
Serum lactate, mmol/L 2.11 (2.6)
Base Deficit 1.50 (5.4)
Anion Gap 9.0 (5.1)
Albumin Corrected Anion Gap 14.1 (3.8)
APACHE II Score 12.8 (7.7)
Mean (s.d.)
Table 3: Sensitivity, specificity and ROC area under the curve for 
AG, ACAG & BD. 
Variable ROC AUC CIs
Anion Gap 0.70 0.64 – 0.77
ACAG 0.72 0.62 – 0.82
Base Deficit 0.79 0.73 – 0.85
Variable Threshold Sensitivity Specificity NPV
Anion Gap 10 63.0% 65.4% 90.0%
12 51.9% 80.0% 90.0%
14 39.5% 88.7% 88.2%
16 27.2% 94.0% 87.0%
ACAG 10 94.4% 15.5% 99.4%
12 88.9% 29.2% 95.3%
14 75.0% 53.5% 94.2%
16 55.6% 74.9% 92.8%
Base Deficit 2 81.5% 66.8% 94.9%
4 63.0% 80.4% 91.8%
6 50.6% 88.1% 90.2%
8 40.7% 91.6% 88.8%
Hyperlactatemia defined as serum lactate > 2.5 mmol/L
ROC AUC = Receiver operator characteristics area under the curve, 
AG = anion gap, ACAG = anion gap corrected for albumin, BD = Base 
Deficit, CI = 95% confidence intervals, NPV = negative predictive 
valueBMC Emergency Medicine 2008, 8:18 http://www.biomedcentral.com/1471-227X/8/18
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with a sensitivity of 63% and a specificity of 80.0% (Table
3). When the threshold of serum lactate is elevated to 4.0
mmol/L, the sensitivity improves to 88.9% and the specif-
icity to 80.4%, but these levels remain unsatisfactory to be
clinically reliable. Unlike AG and BD, ACAG performs
much better for diagnosing the presence  of hyperlac-
tatemia. The diagnostic performance of ACAG improves
considerably with the sensitivity increasing from 63% to
94.4% as compared to the AG (Table 3); however, this
improvement in sensitivity comes at the cost of a low spe-
cificity (29.2%). When the threshold for serum lactate
increases to 4.0 mmol/L, the sensitivity of ACAG improves
to 100% (Table 4), but the specificity remains poor
(29.8%). As a practical matter, the negative predictive
value for ACAG and BD was satisfactory (> 88%), and may
have utility as a tool to rule out the presence of hyperlac-
tatemia.
In order to assess the performance of a test across its diag-
nostic range, ROC curves are useful. Typically, a test with
a high ROC area under the curve signifies a good diagnos-
tic test, and a point on the curve with a high sensitivity
and specificity can be selected for diagnostic purposes. In
the case the anion gap (AG or ACAG) the cut-off point has
been determined by clinical practice (10–12 meq/L). At
this preset threshold, AG does not perform well enough to
be clinically reliable (Table 3). However, ACAG can be
used for the purpose of ruling out the presence for hyper-
lactatemia and severe hyperlactatemia (Table 4). Yet, it is
important to recognize that if serum albumin is not meas-
ured contemporaneously with the serum electrolytes, this
relationship does not hold as evidenced by our previous
study.[15]
In contrast to our previous study when we assessed ICU
admission lab data.[15], BD, AG, and ACAG perform sig-
nificantly better when the serum lactate, blood gas, and
serum electrolytes are drawn from the same sample.
Despite this relative improvement, neither AG nor BD
possess adequate diagnostic capacity for routine clinical
use to rule in or rule out hyperlactatemia, a finding con-
sistent with previous investigations. Iberti et al showed in
a cohort of critically ill patients that only 21% of patients
with a serum lactate level between 2.5 mmol/L and 4.9
mmol/L had an elevated anion gap, consistent with other
studies.[8,10-12] Other studies have shown that as the
serum lactate rises to 4.0–5.0 mmol/L, an elevated anion
gap and base deficit become more specific at detecting
severe hyperlactatemia.[10,17] The performance of ACAG
to diagnose the presence of hyperlactatemia has been
assessed in two limited previous studies. Moviat et al
showed in small series of samples of critically patients
with metabolic acidosis that ACAG had improved sensi-
tivity but worse specificity for detecting the presence of
hyperlactatemia. We verify these findings of Moviat[18] et
al in a larger (497 samples compared to 50) more diverse
population of critically ill patients. Additionally, we tested
the sensitivity and specificity in varying thresholds of
serum lactate. Dinh[19] et al conducted a retrospective
study in a large cohort of hospitalized patients. In that
study, ACAG was no better than AG in predicting the pres-
ence of hyperlactatemia, and both were shown to be poor
diagnostic tools for the diagnosis of hyperlactatemia. In
contrast to their study, our study assessed arterial samples
as opposed to peripheral venous samples; arterial samples
are fully 'mixed' and less apt to regional error (e.g. tourni-
quet effects during phlebotomy, differences in limb flow
and oxygen consumption etc.). We were also able to assess
the performance of base deficit. A review of previous stud-
ies' assessment of BD, AG, and ACAG for the diagnosis of
hyperlactatemia is provided in Table 5.
The implications of these data are noteworthy. Because
elevated serum lactate levels identify patients who are at
high risk of death and may identify patients in shock
before they become hypotensive (a condition called cryp-
tic shock), early recognition and treatment of hyperlac-
tatemia is critical, and likely improves mortality.[7] In
order to institute appropriate therapy as timely as possi-
ble, screening tests for shock should offer as early a warn-
ing as possible, well before the serum lactate rises to 4.0–
5.0 mmol/L. For these reasons, the routine use of AG, BD,
Table 4: Sensitivity, specificity and ROC area under the curve for 
AG, ACAG & BD. 
Variable ROC AUC CIs
Anion Gap 0.87 0.82 – 0.93
ACAG 0.95 0.91–0.99
Base Deficit 0.78 0.71 – 0.86
Variable Threshold Sensitivity Specificity NPV
Anion Gap 10 88.9% 65.7% 98.3%
12 82.2% 80.4% 97.8%
14 66.7% 89.2% 96.4%
16 48.9% 94.5% 94.9%
ACAG 10 100% 15.1% 100%
12 100% 29.8% 100%
14 100% 51.5% 100%
16 92.9% 74.4% 99.5%
Base Deficit 2 84.4% 63.3% 97.6%
4 64.4% 77.1% 95.6%
6 51.1% 84.5% 94.5%
8 42.2% 89.5% 93.9%
Hyperlactatemia defined as Lactate > 4.0 mmol/L
ROC AUC = Receiver operator characteristics area under the curve, 
AG = anion gap, ACAG = anion gap corrected for albumin, BD = Base 
Deficit, CI = 95% confidence intervals, NPV = Negative Predictive 
ValueBMC Emergency Medicine 2008, 8:18 http://www.biomedcentral.com/1471-227X/8/18
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and ACAG as screening tests to determine the presence or
absence of hyperlactatemia, in our opinion, is unaccepta-
ble and potentially harmful. While it is true that the AG
and BD detect the presence of hyperlactatemia more effec-
tively as the threshold value for lactate is raised (serum
lactate > 4.0 mmol/L), waiting to diagnose hyperlac-
tatemia by allowing the level to rise may delay appropriate
intervention. An ACAG < 10 meq/L appears to effectively
rule out the presence of hyperlactatemia, but the serum
albumin and serum electrolytes must be cotemporaneous
and from the same sample in order for that relationship to
be valid. Given that accurate and rapid serum lactate con-
centration measurement is now widely available to all
major hospitals (central labs and/or point of service test-
ing), serum lactate concentrations should be routinely
measured upon admission to the ICU, for many patients
in the emergency department, and in our opinion should
be considered an index laboratory measure. Serum lactate
remains an assay that must be requested separately in
most ICUs and emergency departments; therefore, a clini-
cian must actively ask for this test (Table 1). Further, the
use of anion gap and base deficit to diagnose the presence
or absence of hyperlactatemia is still commonly taught to
medical students and physicians in training. As clinicians
and teachers, we need to correct this misperception in
order to identify patients with hyperlactatemia promptly.
In this study, the shortcomings of using the AG to assess
metabolic acidosis were exposed. As expected, the sensi-
tivity of anion gap improves when the anion gap is cor-
rected for albumin (ACAG). However, the specificity of
the ACAG remained low. The reason for this is illustrated
in Figure 1 and Figure 2. In these plots, ALCAG (albumin
and lactate corrected anion gap) is plotted against the
serum lactate (Figure 1) and pH (Figure 2). Throughout
the range of serum lactate and pH, the quantity of
Table 5: Summary of previous studies
Anion Gap Studies
Study N Sensitivity Specificity ROC
Iberti et al[8] 56 21% Not Reported Not Reported
Levraut et al[10] 498 44% 91% 0.79
Moviat et al[18] 50 45% 16% Not Reported
Dinh et al[19] 356 39% 89% 0.76
Chawla et al[15] 285 15% 94% 0.55
Anion Gap Corrected for Albumin Studies
Study N Sensitivity Specificity ROC
Moviat et al[18] 50 100% 11% Not Reported
Dinh et al[19] 356 75% 59% 0.75
Chawla et al[15] 285 32% 80% 0.57
Base Deficit Studies
Study N Results
Mikulaschek et al[11] 52 No correlation between lactate and base deficit
Waters et al [11,24] 12 Base deficit not useful, instead misleading
Chawla et al[15] 285 Base Deficit not useful, ROC AUC = 0.64
ROC = Receiver operator characteristics area under the curve, AG = anion gap, ACAG = anion gap corrected for albumin, BD = Base Deficit, 
sensitivity and specificity for AG and ACAG are reported at threshold of 12
Table 6: Subset of patients with creatinine > 2.0 mg/dl excluded
ROC Area Under the Curve for AG, ACAG & BD
Hyperlactatemia defined as serum lactate > 2.5 mmol/L
Variable ROC AUC CIs
Anion Gap 0.68 0.59 – 0.77
ACAG 0.71 0.59 – 0.84
Base Deficit 0.77 0.69 – 0.85
ROC Area Under the Curve for AG, ACAG & BD
Hyperlactatemia defined as serum lactate > 4.0 mmol/L
Variable ROC AUC CIs
Anion Gap 0.90 0.83 – 0.97
ACAG 0.96 0.91–0.99
Base Deficit 0.75 0.62 – 0.88BMC Emergency Medicine 2008, 8:18 http://www.biomedcentral.com/1471-227X/8/18
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unmeasured anions is considerable. The mean ALCAG for
the entire cohort was 12.6 ± 3.61. Given that patients with
toxic, ingestions, uremia, and those with ketoacidosis
were excluded and that lactate and serum albumin are
accounted for in the ALCAG equation, the amount of
unmeasured anions in this cohort of critically ill patients
is elevated. In order to better quantify these anions, the
Fencl-Stewart methodology for acid-base assessment
would be preferable.[20] In this approach, the unmeas-
ured anions can be assessed because the strong ion differ-
ence (apparent and effective) is directly measured. This
methodology involves the cotemporaneous measurement
of the serum sodium, potassium, magnesium, chloride,
lactate, pH, phosphorus, pCO2, and serum albumin.[21]
In this cohort, the magnesium, phosphorus, and calcium
were not consistently available in order to measure the
true quantity of the unmeasured anions (strong ion gap).
Because we do not have all the requisite information to
calculate the strong ion gap (SIG), we cannot be certain
that the ALCAG is representative of the SIG. In one small
study, the SIG and the ALCAG were highly correlated (r2 =
0.934, p < 0.0001).[18] We hypothesize that the ALCAG
may be an easy bedside measurement that may approxi-
mate the SIG in patients who are critically ill. Further
research of this relationship in large diverse populations is
warranted. The etiology of the unmeasured anions com-
monly found in critically ill patients has been described.
In patients with lactic acidosis and in patients with 'unex-
plained anion gap acidosis' and normal serum lactates,
plasma concentrations of acids associated with the Krebs
cycle are significantly elevated.[22] The unmeasured iden-
tified anions are: citrate, isocitrate, α-ketoglutarate, succi-
nate, maleate, and d-lactate. Because these acids are often
tri- and di- basic, smaller concentrations can have larger
effects on the anion gap. Unmeasured anions as quanti-
fied by the Fencl-Stewart methodology predict outcomes
Albumin lactate corrected anion gap (ALCAG) v. serum lactate Figure 1
Albumin lactate corrected anion gap (ALCAG) v. serum lactate.BMC Emergency Medicine 2008, 8:18 http://www.biomedcentral.com/1471-227X/8/18
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in critically ill patients better than serum lactate.[23] The
etiology for why these anions are increased in critically ill
patients is unknown, but mitochondrial dysfunction and
cellular cytopathic hypoxia as well as disordered glycolytic
effects have been proposed.[22] We speculate that the
quantity of these unmeasured anions in relationship to
the serum lactate (unmeasured anions to lactate ratio)
may provide a means for assessing the etiology of lactic
acidosis and/or as a predictor of mortality. Further
research is warranted.
Limitations
Our study was conducted in 143 patients with over 497
cotemporaneous samples. Ideally we would have been
able to perform this study in a larger population in order
to maximize our power. In addition, physical chemistry
assessments for unmeasured anions could not be con-
ducted in this cohort. Validation of these data in future
cohorts of patients will need to be conducted.
Conclusion
AG, ACAG, and BD failed to detect the presence of clini-
cally significant hyperlactatemia. The assessment of AG in
critically ill patients is highly limited given the prevalence
of hypoalbuminemia. If an assessment of the AG is
needed, it should be done in concert with serum albumin
and serum lactate measurements (ACAG and ALCAG). We
believe that serum lactate levels should be routinely
obtained in all patients admitted to the ICU in whom the
possibility of shock/hypoperfusion is being considered.
Unmeasured anions exclusive of serum lactate and serum
Albumin lactate corrected anion gap (ALCAG) v. pH Figure 2
Albumin lactate corrected anion gap (ALCAG) v. pH.Publish with BioMed Central    and   every 
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albumin are frequently present in significant quantities in
patients who are critically ill.
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